Success in New Era of Biopharmaceutical Innovation

Driven by significant investments in research and development, there are more than 7,800 products in clinical development spanning a wide range of therapeutic areas—from cancer to cardiovascular medicine and diabetes to neurology. And the fast-growing pipeline includes products that may provide physicians with new approaches to combat diseases, as nearly 70 percent of clinical-phase projects have the potential to best first-in-class treatments. While scientific advances and innovation across the biopharmaceutical industry offer tremendous hope for patients worldwide, the path to commercialization is complex and can be fraught with challenges.

To know more please visit : https://www.fiercepharma.com/sponsored/driving-commercial-success-new-era-biopharmaceutical-innovation